Reconstitution of Human Keloids in Mouse Skin
Overview
Authors
Affiliations
Background: Keloids are a dermal fibroproliferative scar of unknown etiology. There is no good animal model for the study of keloids, which hinders the development and assessment of treatments for keloids.
Methods: Human keratinocytes and dermal fibroblasts were isolated from 3 human skin tissues: normal skin, white scars, and keloids. A mixed-cell slurry containing keratinocytes and dermal fibroblasts was poured into a double chamber implanted on the back of NOD/Shi-scid/IL-2Rγnull mice. After 12 weeks, the recipient mice had developed reconstituted human skin tissues on their backs. These were harvested for histological studies.
Results: Macroscopically, the reconstituted skins derived from both normal skin and white scars were similar to normal skin and white scars in humans, respectively. Keloid-derived reconstituted skins exhibited keloid-like hypertrophic nodules. Histological findings and immunohistochemical staining confirmed that the reconstituted skin tissues were of human origin and the keloid-derived reconstituted skin had the typical features of human keloids such as a hypertrophic dermal nodule, collagen type composition, orientation of collagen fibers, and versican expression.
Conclusion: The mouse model with humanized keloid tissue presented here should be a useful tool for future keloid research.
Xia Y, Wang Y, Hao Y, Shan M, Liu H, Liang Z Front Immunol. 2023; 14:1106289.
PMID: 37275903 PMC: 10235510. DOI: 10.3389/fimmu.2023.1106289.
Human In Vitro Skin Models for Wound Healing and Wound Healing Disorders.
Hofmann E, Fink J, Pignet A, Schwarz A, Schellnegger M, Nischwitz S Biomedicines. 2023; 11(4).
PMID: 37189674 PMC: 10135654. DOI: 10.3390/biomedicines11041056.
Arjunan S, Gan S, Choolani M, Raj V, Lim J, Biswas A Stem Cell Res Ther. 2020; 11(1):78.
PMID: 32085797 PMC: 7035736. DOI: 10.1186/s13287-020-01609-7.
Animal Models for Studies of Keloid Scarring.
Supp D Adv Wound Care (New Rochelle). 2019; 8(2):77-89.
PMID: 31832272 PMC: 6906757. DOI: 10.1089/wound.2018.0828.
Inhibition as a Novel Therapeutic Target for Keloid Disease.
Park T, Kim C, Choi J, Park Y, Chong Y, Park M Adv Wound Care (New Rochelle). 2019; 8(5):186-194.
PMID: 31119062 PMC: 6529855. DOI: 10.1089/wound.2018.0910.